Royalty Pharma Price to Free Cash Flow Ratio 2019-2021 | RPRX
Historical price to free cash flow ratio values for Royalty Pharma (RPRX) since 2019.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
|Royalty Pharma Price to Free Cash Flow Ratio Historical Data
||TTM FCF per Share
||Price to FCF Ratio
||Finance - Miscellaneous Services
Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko and Trikafta, and development-stage product candidates. Royalty Pharma plc is based in NEW YORK.